Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells-Reference-Cited by-同舟云学术

Dual Targeted Immunotherapy via In Vivo Delivery of Biohybrid RNAi-Peptide Nanoparticles to Tumor-Associated Macrophages and Cancer Cells

Published:2015-06-01 Issue:27 Volume:25 Page:4183-4194
ISSN:1616-301X
Container-title:Advanced Functional Materials
language:en
Short-container-title:Adv. Funct. Mater.

Author:

Conde João¹²,Bao Chenchen³,Tan Yeqi⁴,Cui Daxiang³,Edelman Elazer R.¹⁵,Azevedo Helena S.²,Byrne Hugh J.⁴,Artzi Natalie¹⁶,Tian Furong⁴

Affiliation:

1. Massachusetts Institute of Technology; Institute for Medical Engineering and Science; Harvard-MIT Division for Health Sciences and Technology; Cambridge MA 02139 USA

2. School of Engineering and Materials Science; Queen Mary University of London; London UK

3. Institute of Nano Biomedicine and Engineering; Key Laboratory of Thin Film and Micro/Nano Fabrication Technology of Ministry of Education; School of Electronic Information and Electronical Engineering; National Center for Translational Medicine; Shanghai Jiao Tong University; Shanghai 200240 P. R. China

4. Focas Research Institute; Dublin Institute of Technology; Camden Row; Dublin 8 Ireland

5. Cardiovascular Division, Department of Medicine; Brigham and Women's Hospital, Harvard Medical School; Boston MA 02115 USA

6. Department of Anesthesiology; Brigham and Women's Hospital, Harvard Medical School; Boston MA 02115 USA

Publisher

Wiley

Subject

Electrochemistry,Condensed Matter Physics,Biomaterials,Electronic, Optical and Magnetic Materials

Reference45 articles.

1. Microenvironmental regulation of tumor progression and metastasis

2. Tumor progression and metastasis

3. Tumour-educated macrophages promote tumour progression and metastasis

4. Hallmarks of Cancer: The Next Generation

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alternative routes for parenteral nucleic acid delivery and related hurdles: highlights in RNA delivery;Expert Opinion on Drug Delivery;2024-09-13

2. Polypeptides-Based Nanocarriers in Tumor Therapy;Pharmaceutics;2024-09-10

3. Unleashing the potential of mRNA: Overcoming delivery challenges with nanoparticles;Bioengineering & Translational Medicine;2024-08-15

4. Engineered nanoparticles for precise targeted drug delivery and enhanced therapeutic efficacy in cancer immunotherapy;Acta Pharmaceutica Sinica B;2024-08

5. Metal-based nanoparticle in cancer treatment: lessons learned and challenges;Frontiers in Bioengineering and Biotechnology;2024-07-11